Suchergebnisse
Katalog
Mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- genes, brca1 11 Treffer
- genes, brca2 9 Treffer
- breast neoplasms 8 Treffer
- genes, ras 8 Treffer
- lung neoplasms 7 Treffer
-
45 weitere Werte:
- carcinoma, non-small-cell lung 5 Treffer
- colorectal neoplasms 5 Treffer
- neoplasms 5 Treffer
- ovarian neoplasms 5 Treffer
- antineoplastic agents 4 Treffer
- genes, tumor suppressor 4 Treffer
- erbb receptors 3 Treffer
- molecular targeted therapy 3 Treffer
- oncogenes 3 Treffer
- translocation, genetic 3 Treffer
- antineoplastic combined chemotherapy protocols 2 Treffer
- brain neoplasms 2 Treffer
- drug resistance, neoplasm 2 Treffer
- gene amplification 2 Treffer
- genetic predisposition to disease 2 Treffer
- genetic testing 2 Treffer
- phosphatidylinositol 3-kinases 2 Treffer
- precision medicine 2 Treffer
- ras proteins 2 Treffer
- retinoblastoma 2 Treffer
- accreditation 1 Treffer
- acrylamides 1 Treffer
- adenocarcinoma 1 Treffer
- aniline compounds 1 Treffer
- antibodies 1 Treffer
- antibodies, monoclonal 1 Treffer
- antineoplastic agents, immunological 1 Treffer
- beta catenin 1 Treffer
- biomarkers, tumor 1 Treffer
- breast neoplasms, male 1 Treffer
- carcinogenesis 1 Treffer
- carcinoma, medullary 1 Treffer
- cell transformation, neoplastic 1 Treffer
- chromosomes, human, pair 8 1 Treffer
- colonic neoplasms 1 Treffer
- disease progression 1 Treffer
- dna mutational analysis 1 Treffer
- epigenesis, genetic 1 Treffer
- estrogen receptor alpha 1 Treffer
- exons 1 Treffer
- exosomes 1 Treffer
- family health 1 Treffer
- fibromatosis, aggressive 1 Treffer
- founder effect 1 Treffer
- fusion proteins, bcr-abl 1 Treffer
Sprache
Geographischer Bezug
Inhaltsanbieter
43 Treffer
-
In: Bulletin du cancer, Jg. 108 (2021-11-01), Heft 11, S. 1044-1056academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 108 (2021-02-01), Heft 2, S. 140-142editorialOpinionZugriff:
-
In: Bulletin du cancer, Jg. 108 (2021), Heft 1, S. 38-40serialPeriodicalZugriff:
-
In: Bulletin du cancer, Jg. 107 (2020-09-01), Heft 9, S. 881-895academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 107 (2020-02-01), Heft 2, S. 145editorialOpinionZugriff:
-
In: Bulletin du cancer, Jg. 105 (2018), Heft 1, S. 46-54academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 104 (2017-07-01), Heft 7-8, S. 662-674academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 104 Suppl 1 (2017-05-01), S. S16-S23academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 104 (2017-03-01), Heft 3, S. 205-207editorialOpinionZugriff:
-
In: Bulletin du cancer, Jg. 103 (2016-06-01), Heft 6 Suppl 1, S. S16-28academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 103 (2016-03-01), Heft 3, S. 273-81academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 102 (2015-12-01), Heft 12, S. 1020-35academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 102 (2015-12-01), Heft 12, S. 966serialPeriodicalZugriff:
-
In: Bulletin du cancer, Jg. 102 (2015-09-01), Heft 9, S. 749-57academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 102 (2015-06-01), Heft 6 Suppl 1, S. S27-33academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 102 (2015-03-01), Heft 3, S. 245-55academicJournalZugriff:
-
Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer.In: Bulletin du cancer, Jg. 102 (2015-02-01), Heft 2, S. 117-25academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 101 (2014-11-01), Heft 11, S. 1001-8academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 101 (2014-10-01), Heft 10, S. 958-65academicJournalZugriff:
-
In: Bulletin du cancer, Jg. 101 (2014-09-01), Heft 9, S. 776-7academicJournalZugriff: